Results 131 to 140 of about 41,111 (239)
Polymyxin-B hemoperfusion inactivates circulating proapoptotic factors [PDF]
OBJECTIVE: To test the hypothesis that extracorporeal therapy with polymyxin B (PMX-B) may prevent Gram-negative sepsis-induced acute renal failure (ARF) by reducing the activity of proapoptotic circulating factors.
Segoloni GP +13 more
core
Rational use of intravenous polymyxin B and colistin: a review [PDF]
Polymyxin B and colistin (polymyxin E) were introduced in clinical practice to treat Gram-negative infections in 1950s but their parenteral use waned in 1970s due to toxicity concerns.
Mohd Nazirul Mubin bin Puteh Ahmad
core
Polymyxin B: Controlled biosynthesis.
L, Withander, H, Heding
openaire +3 more sources
Marine Antimicrobial Peptide as a Promising Alternative to Polymyxin B. [PDF]
Safronova VN +16 more
europepmc +1 more source
Bacterial extracellular vesicles promote membrane repair and tolerance to polymyxin B. [PDF]
Bos J +5 more
europepmc +1 more source
Case Commentary: Intraventricular polymyxin B-small steps, big questions. [PDF]
Kunnathu Puthanveedu ND, Bhimraj A.
europepmc +1 more source
Removal of activated neutrophils by a polymyxin B-immobilized fiber (PMX) column. [PDF]
Miyamoto Y +8 more
europepmc +1 more source
Subconjunctival Injection of Polymyxin B [PDF]
openaire +2 more sources

